Microstructure, pathophysiology, and potential therapeutics of COVID‐19: A comprehensive review

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884 · see citing works

Clinical characteristics of coronavirus disease 2019 in China

Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246 · see citing works

A novel coronavirus from patients with pneumonia in China, 2019

Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001017 · Cited by 28,244 · see citing works

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286 · see citing works

Clinical characteristics of 138 hospitalized patients with 2019 Novel Coronavirus-Infected pneumonia in Wuhan, China

Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y., et al. (2020) · JAMA · doi:10.1001/jama.2020.1585 · Cited by 20,148 · see citing works

La certeza de lo impredecible: Cultura Educación y Sociedad en tiempos de COVID19

Martínez González, M. (2020) · DSPACE System - Metalibrary (University of the Coast) · Cited by 18,463 · see citing works

Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia

Li, Q., Guan, X., Wu, P., Wang, X., Zhou, L., Tong, Y., Ren, R., Leung, K. S. M., Lau, E. H. Y., Wong, J. Y., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001316 · Cited by 16,575 · see citing works

Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding

Lu, R., Zhao, X., Li, J., Niu, P., Yang, B., Wu, H., Wang, W., Song, H., Huang, B., Zhu, N., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30251-8 · Cited by 11,907 · see citing works

COVID-19: consider cytokine storm syndromes and immunosuppression

Mehta, P., McAuley, D. F., Brown, M., Sanchez, E., Tattersall, R. S., & Manson, J. J. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30628-0 · Cited by 9,664 · see citing works

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

Wrapp, D., Wang, N., Corbett, K. S., Goldsmith, J. A., Hsieh, C.-L., Abiona, O., Graham, B. S., & McLellan, J. S. (2020) · Science · doi:10.1126/science.abb2507 · Cited by 8,897 · see citing works

Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein

Walls, A. C., Park, Y.-J., Tortorici, M. A., Wall, A., McGuire, A. T., & Veesler, D. (2020) · doi:10.1101/2020.02.19.956581 · Cited by 8,586 · see citing works

Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR

Corman, V. M., Landt, O., Kaiser, M., Molenkamp, R., Meijer, A., Chu, D. K. W., Bleicker, T., Brünink, S., Schneider, J. A., Schmidt, M. L., et al. (2020) · Eurosurveillance · doi:10.2807/1560-7917.es.2020.25.3.2000045 · Cited by 7,266 · see citing works

Endothelial cell infection and endotheliitis in COVID-19

Varga, Z., Flammer, A. J., Steiger, P., Haberecker, M., Andermatt, R., Zinkernagel, A. S., Mehra, M. R., Schuepbach, R. A., Ruschitzka, F., & Moch, H. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30937-5 · Cited by 6,358 · see citing works

Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor

Lan, J., Ge, J., Yu, J., Shan, S., Zhou, H., Fan, S., Zhang, Q., Shi, X., Wang, Q., Zhang, L., et al. (2020) · Nature · doi:10.1038/s41586-020-2180-5 · Cited by 5,983 · see citing works

The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak

Rothan, H. A., & Byrareddy, S. N. (2020) · Journal of Autoimmunity · doi:10.1016/j.jaut.2020.102433 · Cited by 5,840 · see citing works

Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis

Hamming, I., Timens, W., Bulthuis, M., Lely, A., Navis, G., & van Goor, H. (2004) · The Journal of Pathology · doi:10.1002/path.1570 · Cited by 5,676 · see citing works

Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19

Ackermann, M., Verleden, S. E., Kuehnel, M., Haverich, A., Welte, T., Laenger, F., Vanstapel, A., Werlein, C., Stark, H., Tzankov, A., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2015432 · Cited by 5,613 · see citing works

Origin and evolution of pathogenic coronaviruses

Cui, J., Li, F., & Shi, Z. (2018) · Nature Reviews Microbiology · doi:10.1038/s41579-018-0118-9 · Cited by 5,543 · see citing works

Untitled work

Guo (2020) · doi:10.1186/s40779-020-00240-0 · Cited by 4,735 · see citing works

mRNA vaccines — a new era in vaccinology

Pardi, N., Hogan, M. J., Porter, F. W., & Weissman, D. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.243 · Cited by 4,667 · see citing works

Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus

Wan, Y., Shang, J., Graham, R., Baric, R. S., & Li, F. (2020) · Journal of Virology · doi:10.1128/jvi.00127-20 · Cited by 4,341 · cited 2× · see citing works

Coronaviruses: An Overview of Their Replication and Pathogenesis

Fehr, A. R., & Perlman, S. M. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2438-7_1 · Cited by 3,784 · see citing works

Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals

Grifoni, A., Weiskopf, D., Ramirez, S. I., Mateus, J., Dan, J. M., Moderbacher, C. R., Rawlings, S. A., Sutherland, A., Premkumar, L., Jadi, R. S., et al. (2020) · Cell · doi:10.1016/j.cell.2020.05.015 · Cited by 3,595 · see citing works

Features, Evaluation and Treatment Coronavirus (COVID-19)

Cascella, M., Rajnik, M., Cuomo, A., Dulebohn, S. C., & Napoli, R. D. (2020) · StatPearls · Cited by 3,351 · see citing works

Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV

Ou, X., Liu, Y., Lei, X., Li, P., Mi, D., Ren, L., Guo, L., Guo, R., Chen, T., Hu, J., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15562-9 · Cited by 3,097 · see citing works

Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan

Chan, J. F., Kok, K., Zhu, Z., Chu, H., To, K. K., Yuan, S., & Yuen, K. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1719902 · Cited by 3,063 · see citing works

CRISPR–Cas12-based detection of SARS-CoV-2

Broughton, J. P., Deng, X., Yu, G., Fasching, C. L., Servellita, V., Singh, J., Miao, X., Streithorst, J. A., Granados, A. C., Sotomayor-González, A., et al. (2020) · Nature Biotechnology · doi:10.1038/s41587-020-0513-4 · Cited by 2,737 · see citing works

Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target

Zhang, H., Penninger, J. M., Li, Y., Zhong, N., & Slutsky, A. S. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-05985-9 · Cited by 2,684 · see citing works

Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019

Zhao, J., Yuan, Q., Wang, H., Liu, W., Liao, X., Su, Y., Wang, X., Yuan, J., Li, T., Li, J., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa344 · Cited by 2,607 · see citing works

Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19)

Diao, B., Wang, C., Tan, Y., Chen, X., Liu, Y., Ning, L., Chen, L., Li, M., Liu, Y., Wang, G., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00827 · Cited by 2,475 · see citing works

Transmission routes of 2019-nCoV and controls in dental practice

Peng, X., Xu, X., Li, Y., Cheng, L., Zhou, X., & Ren, B. (2020) · International Journal of Oral Science · doi:10.1038/s41368-020-0075-9 · Cited by 2,436 · see citing works

Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review

Adhikari, S. P., Sha, M., Wu, Y.-J., Mao, Y.-P., Ye, R.-X., Wang, Q.-Z., Sun, C., Sylvia, S., Rozelle, S., Raat, H., et al. (2020) · Infectious Diseases of Poverty · doi:10.1186/s40249-020-00646-x · Cited by 2,410 · see citing works

Genome Composition and Divergence of the Novel Coronavirus (2019-nCoV) Originating in China

Wu, A., Peng, Y., Huang, B., Ding, X. L., Wang, X., Niu, P., Meng, J., Zhu, Z., Zhang, Z., Wang, J., et al. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.02.001 · Cited by 2,363 · see citing works

Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19)

Gomes, C. A. (2020) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 2,226 · see citing works

Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission

Xu, X., Chen, P., Wang, J., Feng, J., Zhou, H., Li, X., Zhong, W., & Hao, P. (2020) · Science China Life Sciences · doi:10.1007/s11427-020-1637-5 · Cited by 2,202 · see citing works

Chloroquine inhibits autophagic flux by decreasing autophagosome-lysosome fusion

Mauthe, M., Orhon, I., Rocchi, C., Zhou, X., Luhr, M., Hijlkema, K.-J., Coppes, R. P., Engedal, N., Mari, M., & Reggiori, F. (2018) · Autophagy · doi:10.1080/15548627.2018.1474314 · Cited by 2,122 · see citing works

Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro

Liu, J., Cao, R., Xu, M., Wang, X., Zhang, H., Hu, H., Li, Y., Hú, Z., Zhong, W., & Wang, M. (2020) · Cell Discovery · doi:10.1038/s41421-020-0156-0 · Cited by 2,070 · see citing works

Evolving functions of endothelial cells in inflammation

Pober, J. S., & Sessa, W. C. (2007) · Nature Reviews Immunology · doi:10.1038/nri2171 · Cited by 2,022 · see citing works

Effectiveness of convalescent plasma therapy in severe COVID-19 patients

Duan, K., Liu, B., Li, C., Zhang, H., Yu, T., Qu, J., Zhou, M., Chen, L., Meng, S., Hu, Y., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2004168117 · Cited by 1,962 · see citing works

Data, disease and diplomacy: GISAID's innovative contribution to global health

Elbe, S., & Buckland‐Merrett, G. (2017) · Global Challenges · doi:10.1002/gch2.1018 · Cited by 1,928 · see citing works

Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases

Dinarello, C., Simon, A., & van der Meer, J. V. D. (2012) · Nature reviews. Drug discovery · doi:10.1038/nrd3800 · Cited by 1,813 · see citing works

Functional exhaustion of antiviral lymphocytes in COVID-19 patients

Zheng, M., Gao, Y., Wang, G., Song, G., Liu, S., Sun, D., Xu, Y., & Tian, Z. (2020) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-0402-2 · Cited by 1,768 · see citing works

Molecular immune pathogenesis and diagnosis of COVID-19

Li, X., Geng, M., Peng, Y., Meng, L., & Lu, S. (2020) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2020.03.001 · Cited by 1,723 · see citing works

The spike protein of SARS-CoV — a target for vaccine and therapeutic development

Du, L., He, Y., Zhou, Y., Liu, S., Zheng, B.-J., & Jiang, S. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2090 · Cited by 1,649 · see citing works

COVID-19 infection: the perspectives on immune responses

Shi, Y., Wang, Y., Shao, C., Huang, J., Gan, J., Huang, X., Bucci, E. M., Piacentini, M., Ippolito, G., & Melino, G. (2020) · Cell Death and Differentiation · doi:10.1038/s41418-020-0530-3 · Cited by 1,602 · see citing works

Developing Covid-19 Vaccines at Pandemic Speed

Lurie, N., Saville, M., Hatchett, R., & Halton, J. (2020) · New England Journal of Medicine · doi:10.1056/nejmp2005630 · Cited by 1,557 · see citing works

COVID-19: towards controlling of a pandemic

Bedford, J., Enria, D., Giesecke, J., Heymann, D. L., Ihekweazu, C., Kobinger, G., Lane, H. C., Memish, Z., Oh, M.-D., Sall, A. A., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30673-5 · Cited by 1,545 · see citing works

Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic

(2020) · Asian Pacific Journal of Allergy and Immunology · doi:10.12932/ap-200220-0772 · Cited by 1,537 · see citing works

Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells

Matsuyama, S., Nao, N., Shirato, K., Kawase, M., Saito, S., Takayama, I., Nagata, N., Sekizuka, T., Katoh, H., Kato, F., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2002589117 · Cited by 1,414 · see citing works

Probable Pangolin Origin of SARS-CoV-2 Associated with the COVID-19 Outbreak

Zhang, T., Wu, Q., & Zhang, Z. (2020) · Current Biology · doi:10.1016/j.cub.2020.03.022 · Cited by 1,397 · see citing works

Potential interventions for novel coronavirus in China: A systematic review

Zhang, L., & Liu, Y. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25707 · Cited by 1,354 · see citing works

Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study.

Ren, L.-L., Wang, Y.-M., Wu, Z.-Q., Xiang, Z.-C., Guo, L., Xu, T., Jiang, Y.-Z., Xiong, Y., Li, Y.-J., Li, X.-W., et al. (2020) · Chinese Medical Journal · doi:10.1097/cm9.0000000000000722 · Cited by 1,349 · see citing works

Research and Development on Therapeutic Agents and Vaccines for COVID-19 and Related Human Coronavirus Diseases

Liu, C., Zhou, Q. A., Li, Y., Garner, L. V., Watkins, S. P., Carter, L. J., Smoot, J., Gregg, A. C., Daniels, A. D., Jervey, S. R., et al. (2020) · ACS Central Science · doi:10.1021/acscentsci.0c00272 · Cited by 1,304 · see citing works

The cytokine storm in COVID-19: an overview of the involvement of the chemokine/chemokine-receptor system

Coperchini, F., Chiovato, L., Croce, L., Magri, F., & Rotondi, M. (2020) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2020.05.003 · Cited by 1,288 · see citing works

Molecular Diagnosis of a Novel Coronavirus (2019-nCoV) Causing an Outbreak of Pneumonia

Chu, D. K. W., Pan, Y., Cheng, S. M. S., Hui, K. P. Y., Krishnan, P., Liu, Y., Ng, D. Y. M., Wan, C. K. C., Yang, P., Wang, Q., et al. (2020) · Clinical Chemistry · doi:10.1093/clinchem/hvaa029 · Cited by 1,278 · see citing works

Effects of chloroquine on viral infections: an old drug against today's diseases

Savarino, A., Boelaert, J. R., Cassone, A., Majori, G., & Cauda, R. (2003) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(03)00806-5 · Cited by 1,272 · see citing works

COVID-19 cytokine storm: the interplay between inflammation and coagulation

José, R. J. P., & Manuel, A. R. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30216-2 · Cited by 1,241 · see citing works

The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice

Bao, L., Deng, W., Huang, B., Gao, H., Liu, J., Ren, L., Wei, Q., Yu, P., Xu, Y., Qi, F., et al. (2020) · Nature · doi:10.1038/s41586-020-2312-y · Cited by 1,126 · see citing works

Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies

Ahmed, S. F., Quadeer, A. A., & McKay, M. R. (2020) · Viruses · doi:10.3390/v12030254 · Cited by 1,116 · see citing works

SARS-CoV-2 infection: The role of cytokines in COVID-19 disease

Costela-Ruiz, V. J., Montes, R. I., Puerta, J. M., Ruíz, C., & Melguizo‐Rodríguez, L. (2020) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2020.06.001 · Cited by 1,110 · see citing works

Understanding of COVID‐19 based on current evidence

Sun, P., Lu, X., Xu, C., Sun, W., & Pan, B. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25722 · Cited by 1,107 · see citing works

2019-nCoV transmission through the ocular surface must not be ignored

Lu, C., Liu, X., & Jia, Z. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30313-5 · Cited by 1,071 · see citing works

Convalescent plasma as a potential therapy for COVID-19

Chen, L., Xiong, J., Bao, L., & Shi, Y. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30141-9 · Cited by 1,038 · see citing works

COVID-19 and Multiorgan Response

Zaim, S., Chong, J. H., Sankaranarayanan, V., & Harky, A. (2020) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2020.100618 · Cited by 1,032 · see citing works

SARS-CoV-2: an Emerging Coronavirus that Causes a Global Threat

Zheng, J. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.45053 · Cited by 1,030 · see citing works

COVID-19: the vasculature unleashed

Teuwen, L.-A. M. N., Geldhof, V., Pasut, A., & Carmeliet, P. (2020) · Nature reviews. Immunology · doi:10.1038/s41577-020-0343-0 · Cited by 1,010 · see citing works

Current Status of Epidemiology, Diagnosis, Therapeutics, and Vaccines for Novel Coronavirus Disease 2019 (COVID-19)

Ahn, D., Shin, H.-J., Kim, M.-H., Lee, S.-H., Kim, H.-S., Myoung, J., Kim, B., & Kim, S. (2020) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.2003.03011 · Cited by 997 · see citing works

Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19

Thevarajan, I., Nguyen, T. H. O., Koutsakos, M., Druce, J. D., Caly, L., van de Sandt, C. E., Jia, X., Nicholson, S. R., Catton, M. C., Cowie, B., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0819-2 · Cited by 993 · see citing works

Assay Techniques and Test Development for COVID-19 Diagnosis

Carter, L. J., Garner, L. V., Smoot, J., Li, Y., Zhou, Q. A., Saveson, C. J., Sasso, J. M., Gregg, A. C., Soares, D. J., Beskid, T. R., et al. (2020) · ACS Central Science · doi:10.1021/acscentsci.0c00501 · Cited by 987 · see citing works

Zoonotic origins of human coronaviruses

Ye, Z., Yuan, S., Yuen, K., Fung, S., Chan, C., & Jin, D. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.45472 · Cited by 944 · see citing works

The Coronavirus Nucleocapsid Is a Multifunctional Protein

McBride, R., van Zyl, M., & Fielding, B. C. (2014) · Viruses · doi:10.3390/v6082991 · Cited by 928 · see citing works

A Sequence Homology and Bioinformatic Approach Can Predict Candidate Targets for Immune Responses to SARS-CoV-2

Grifoni, A., Sidney, J., Zhang, Y., Scheuermann, R. H., Peters, B., & Sette, A. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.03.002 · Cited by 920 · see citing works

Single-Cell RNA Expression Profiling of ACE2, the Receptor of SARS-CoV-2

Zhao, Y., Zhao, Z., Wang, Y., Zhou, Y., Ma, Y., & Zuo, W. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202001-0179le · Cited by 916 · see citing works

Structure of the SARS-CoV nsp12 polymerase bound to nsp7 and nsp8 co-factors

Kirchdoerfer, R. N., & Ward, A. B. (2019) · Nature Communications · doi:10.1038/s41467-019-10280-3 · Cited by 899 · see citing works

Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection

de Wit, E., Feldmann, F., Cronin, J., Jordan, R., Okumura, A., Thomas, T., Scott, D. P., Cihlář, T., & Feldmann, H. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1922083117 · Cited by 888 · see citing works

Plasma IP-10 and MCP-3 levels are highly associated with disease severity and predict the progression of COVID-19

Yang, Y., Shen, C., Li, J., Yuan, J., Wei, J., Huang, F., Wang, F., Li, G., Li, Y., Xing, L., et al. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.04.027 · Cited by 872 · see citing works

Pathogenesis of COVID-19 from a cell biology perspective

Mason, R. J. (2020) · European Respiratory Journal · doi:10.1183/13993003.00607-2020 · Cited by 865 · see citing works

Single-cell RNA expression profiling of ACE2, the receptor of SARS-CoV-2

Zhao, Y., Zhao, Z., Wang, Y., Zhou, Y., Ma, Y., & Zuo, W. (2020) · doi:10.1101/2020.01.26.919985 · Cited by 860 · see citing works

The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus

Gordon, C. J., Tchesnokov, E. P., Feng, J. Y., Porter, D., & Götte, M. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ac120.013056 · Cited by 853 · see citing works

Community Transmission of Severe Acute Respiratory Syndrome Coronavirus 2, Shenzhen, China, 2020

Liu, J., Liao, X., Qian, S., Yuan, J., Wang, F., Liu, Y., Wang, Z., Wang, F.-S., Liu, L., & Zhang, Z. (2020) · Emerging infectious diseases · doi:10.3201/eid2606.200239 · Cited by 793 · see citing works

The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cellsPreprint

Hoffmann, M., Kleine‐Weber, H., Krüger, N., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.01.31.929042 · Cited by 754 · see citing works

Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event

Paraskevis, D. N., Kostaki, E. G., Magiorkinis, G., Panayiotakopoulos, G., Sourvinos, G., & Tsiodras, S. (2020) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2020.104212 · Cited by 753 · see citing works

Why are RNA virus mutation rates so damn high?

Duffy, S. (2018) · PLoS Biology · doi:10.1371/journal.pbio.3000003 · Cited by 750 · see citing works

Anti-HCV, nucleotide inhibitors, repurposing against COVID-19

Elfiky, A. A. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117477 · Cited by 719 · see citing works

Composition and divergence of coronavirus spike proteins and host ACE2 receptors predict potential intermediate hosts of SARS‐CoV‐2

Liu, Z., Xiao, X., Wei, X., Li, J., Yang, J., Tan, H., Zhu, J., Zhang, Q., Wu, J., & Liu, L. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25726 · Cited by 684 · see citing works

A decade after SARS: strategies for controlling emerging coronaviruses

Graham, R. L., Donaldson, E., & Baric, R. S. (2013) · Nature Reviews Microbiology · doi:10.1038/nrmicro3143 · Cited by 676 · see citing works

COVID-19: Immunology and treatment options

Felsenstein, S., Herbert, J. A., McNamara, P. S., & Hedrich, C. M. (2020) · Clinical Immunology · doi:10.1016/j.clim.2020.108448 · Cited by 669 · see citing works

Molecular Mechanism for Antibody-Dependent Enhancement of Coronavirus Entry

Wan, Y., Shang, J., Sun, S., Tai, W., Chen, J., Geng, Q., He, L., Chen, Y., Wu, J., Shi, Z., et al. (2019) · Journal of Virology · doi:10.1128/jvi.02015-19 · Cited by 662 · see citing works

Genetic diversity and evolution of SARS-CoV-2

Phan, T. G. (2020) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2020.104260 · Cited by 629 · see citing works

COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics

Dhama, K., Sharun, K., Tiwari, R., Dadar, M., Malik, Y. S., Singh, K. P., & Chaicumpa, W. (2020) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2020.1735227 · Cited by 622 · see citing works

New insights into the antiviral effects of chloroquine

Savarino, A., Trani, L. D., Donatelli, I., Cauda, R., & Cassone, A. (2006) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(06)70361-9 · Cited by 570 · see citing works

Severe Acute Respiratory Syndrome Coronavirus Envelope Protein Ion Channel Activity Promotes Virus Fitness and Pathogenesis

Nieto-Torres, J. L., DeDiego, M. L., Verdiá-Báguena, C., Jiménez-Guardeño, J. M., Regla-Nava, J. Á., Fernández‐Delgado, R., Castaño-Rodríguez, C., Alcaraz, A., Torres, J., Aguilella, V. M., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004077 · Cited by 560 · see citing works

Potential Rapid Diagnostics, Vaccine and Therapeutics for 2019 Novel Coronavirus (2019-nCoV): A Systematic Review

Pang, J., Wang, M. X., Ang, I. Y. H., Tan, S. H. X., Lewis, R. F., Chen, J. I., Gutiérrez, R. A., Gwee, S. X. W., Chua, P. E. Y., Yang, Q., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9030623 · Cited by 553 · see citing works

The SARS-CoV-2 Vaccine Pipeline: an Overview

Chen, W., Strych, U., Hotez, P. J., & Bottazzi, M. E. (2020) · Current Tropical Medicine Reports · doi:10.1007/s40475-020-00201-6 · Cited by 512 · see citing works

Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019Preprint

Zhao, J., Yuan, Q., Wang, H., et al. (2020) · medRxiv · doi:10.1101/2020.03.02.20030189 · Cited by 510 · see citing works

Structural basis and functional analysis of the SARS coronavirus nsp14–nsp10 complex

Ma, Y., Wu, L., Shaw, N., Gao, Y., Wang, J., Sun, Y., Lou, Z., Yan, L., Zhang, R., & Rao, Z. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1508686112 · Cited by 488 · see citing works

Rapid reconstruction of SARS-CoV-2 using a synthetic genomics platform

Thao, T. T. N., Labroussaa, F., Ebert, N., V’kovski, P., Stalder, H., Portmann, J., Kelly, J. N., Steiner, S., Holwerda, M., Kratzel, A., et al. (2020) · Nature · doi:10.1038/s41586-020-2294-9 · Cited by 485 · see citing works

Identification of Coronavirus Isolated from a Patient in Korea with COVID-19

Kim, J., Chung, Y., Jo, H. J., Lee, N., Kim, M. S., Woo, S., Park, S., Kim, J. W., Kim, H. M., & Han, M. G. (2020) · Osong Public Health and Research Perspectives · doi:10.24171/j.phrp.2020.11.1.02 · Cited by 478 · see citing works

Coronavirus puts drug repurposing on the fast track

Harrison, C. (2020) · Nature Biotechnology · doi:10.1038/d41587-020-00003-1 · Cited by 474 · see citing works

IFITM-Family Proteins: The Cell's First Line of Antiviral Defense

Bailey, C. C., Zhong, G., Huang, I., & Farzan, M. (2014) · Annual Review of Virology · doi:10.1146/annurev-virology-031413-085537 · Cited by 470 · see citing works

Middle East Respiratory Syndrome Coronavirus Infection Mediated by the Transmembrane Serine Protease TMPRSS2

Shirato, K., Kawase, M., & Matsuyama, S. (2013) · Journal of Virology · doi:10.1128/jvi.01890-13 · Cited by 448 · see citing works

Associations between immune-suppressive and stimulating drugs and novel COVID-19—a systematic review of current evidence

Russell, B. A., Moss, C. L., George, G., Santaolalla, A., Cope, A. P., Papa, S., & Hemelrijck, M. V. (2020) · ecancermedicalscience · doi:10.3332/ecancer.2020.1022 · Cited by 440 · see citing works

Probable Pangolin Origin of SARS-CoV-2 Associated with the COVID-19 Outbreak

Zhang, T., Wu, Q., & Zhang, Z. (2020) · Current Biology · doi:10.1016/j.cub.2020.03.063 · Cited by 428 · see citing works

Novel coronavirus 2019-nCoV: prevalence, biological and clinical characteristics comparison with SARS-CoV and MERS-CoV.

Meo, S. A., Alhowikan, A. M., Al-khlaiwi, T., Meo, I. M. U., Halepoto, D. M., Iqbal, M., Usmani, A. M., Hajjar, W. M., & Ahmed, N. (2020) · PubMed · doi:10.26355/eurrev_202002_20379 · Cited by 426 · see citing works

Antibody-dependent SARS coronavirus infection is mediated by antibodies against spike proteins

Wang, S., Tseng, S., Yen, C., Yang, J.-Y., Tsao, C.-H., Shen, C.-W., Chen, K.-H., Liu, F., Liu, W.-T., Chen, Y. A., et al. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.07.090 · Cited by 421 · see citing works

T-cell immunity of SARS-CoV: Implications for vaccine development against MERS-CoV

Liu, W. J., Zhao, M. J., Liu, K., Xu, K., Wong, G., Tan, W., & Gao, G. F. (2016) · Antiviral Research · doi:10.1016/j.antiviral.2016.11.006 · Cited by 395 · see citing works

Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China

Yu, F., Du, L., Ojcius, D. M., Pan, C., & Jiang, S. (2020) · Microbes and Infection · doi:10.1016/j.micinf.2020.01.003 · Cited by 386 · see citing works

Contributions of the structural proteins of severe acute respiratory syndrome coronavirus to protective immunity

Buchholz, U. J., Bukreyev, A. A., Yang, L., Lamirande, E. W., Murphy, B. R., Subbarao, K., & Collins, P. L. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403492101 · Cited by 385 · see citing works

A tug-of-war between severe acute respiratory syndrome coronavirus 2 and host antiviral defence: lessons from other pathogenic viruses

Fung, S., Yuen, K., Ye, Z., Chan, C., & Jin, D. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1736644 · Cited by 383 · see citing works

Development of epitope‐based peptide vaccine against novel coronavirus 2019 (SARS‐COV‐2): Immunoinformatics approach

Bhattacharya, M., Sharma, A. R., Patra, P., Ghosh, P., Sharma, G., Patra, B. C., Lee, S., & Chakraborty, C. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25736 · Cited by 381 · see citing works

Spike protein recognition of mammalian ACE2 predicts the host range and an optimized ACE2 for SARS-CoV-2 infection

Luan, J., Lu, Y., Jin, X., & Zhang, L. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.03.047 · Cited by 379 · see citing works

Detectable 2019-nCoV viral RNA in blood is a strong indicator for the further clinical severity

Chen, W., Lan, Y., Yuan, X.-Z., Deng, X., Li, Y., Cai, X., Li, L., He, R., Tan, Y., Deng, X., et al. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1732837 · Cited by 378 · see citing works

Convalescent plasma transfusion for the treatment of COVID‐19: Systematic review

Rajendran, K., Narayanasamy, K., Rangarajan, J., Rathinam, J., Natarajan, M., & Ramachandran, A. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25961 · Cited by 359 · see citing works

In Vitro Diagnostic Assays for COVID-19: Recent Advances and Emerging Trends

Vashist, S. K. (2020) · Diagnostics · doi:10.3390/diagnostics10040202 · Cited by 336 · see citing works

Facing COVID-19 in the ICU: vascular dysfunction, thrombosis, and dysregulated inflammation

Leisman, D. E., Deutschman, C. S., & Legrand, M. M. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-06059-6 · Cited by 332 · see citing works

An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies

Jiang, S., Du, L., & Shi, Z. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1723441 · Cited by 330 · see citing works

A distinct name is needed for the new coronavirus

Jiang, S., Shi, Z., Shu, Y., Song, J., Gao, G. F., Tan, W., & Guo, D. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30419-0 · Cited by 329 · see citing works

Antibody-Dependent Enhancement of Virus Infection and Disease

Cancel-Tirado, S. M., & Yoon, K. J. (2003) · Viral Immunology · doi:10.1089/088282403763635465 · Cited by 316 · see citing works

Coronavirus 2019-nCoV: A brief perspective from the front line

Han, Q., Lin, Q., Jin, S., & You, L. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.02.010 · Cited by 313 · see citing works

Viral Kinetics and Antibody Responses in Patients with COVID-19Preprint

Tan, W., Lu, Y., Zhang, J., Wang, J., Dan, Y., Tan, Z., He, X., Qian, C., Sun, Q., Hu, Q., et al. (2020) · medRxiv · doi:10.1101/2020.03.24.20042382 · Cited by 303 · see citing works

Ensuring global access to COVID-19 vaccines

Yamey, G., Schäferhoff, M., Hatchett, R. J., Pate, M. A., Zhao, F., & McDade, K. K. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30763-7 · Cited by 298 · see citing works

Novel coronavirus: From discovery to clinical diagnostics

Phan, T. G. (2020) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2020.104211 · Cited by 297 · see citing works

Monalizumab: inhibiting the novel immune checkpoint NKG2A

van Hall, T., André, P., Horowitz, A., Ruan, D. F., Borst, L., Zerbib, R. A., Narni-Mancinelli, É., van der Burg, S. H., & Vivier, É. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-019-0761-3 · Cited by 292 · see citing works

Human Challenge Studies to Accelerate Coronavirus Vaccine Licensure

Eyal, N., Lipsitch, M., & Smith, P. G. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa152 · Cited by 283 · see citing works

Progress and Prospects on Vaccine Development against SARS-CoV-2

Zhang, J., Zeng, H., Gu, J., Li, H., Zheng, L., & Zou, Q. (2020) · Vaccines · doi:10.3390/vaccines8020153 · Cited by 280 · see citing works

The COVID-19 pandemic calls for spatial distancing and social closeness: not for social distancing!

Abel, T., & McQueen, D. V. (2020) · International Journal of Public Health · doi:10.1007/s00038-020-01366-7 · Cited by 276 · see citing works

Exuberant elevation of IP-10, MCP-3 and IL-1ra during SARS-CoV-2 infection is associated with disease severity and fatal outcomePreprint

Yang, Y., Shen, C., Li, J., et al. (2020) · medRxiv · doi:10.1101/2020.03.02.20029975 · Cited by 274 · see citing works

Immunoinformatics‐aided identification of T cell and B cell epitopes in the surface glycoprotein of 2019‐nCoV

Baruah, V., & Bose, S. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25698 · Cited by 270 · see citing works

Dual Role of GM-CSF as a Pro-Inflammatory and a Regulatory Cytokine: Implications for Immune Therapy

Bhattacharya, P., Budnick, I., Singh, M., Thiruppathi, M., Alharshawi, K., Elshabrawy, H. A., Holterman, M., & Prabhakar, B. S. (2015) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2014.0149 · Cited by 264 · see citing works

Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2

Zhou, G., & Zhao, Q. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.45123 · Cited by 262 · see citing works

Biologics for targeting inflammatory cytokines, clinical uses, and limitations

Rider, P., Carmi, Y., & Cohen, I. (2016) · International Journal of Cell Biology · doi:10.1155/2016/9259646 · Cited by 226 · see citing works

Recent Advances in the Vaccine Development Against Middle East Respiratory Syndrome-Coronavirus

Yong, C. Y., Ong, H. K., Yeap, S. K., Ho, K. L., & Tan, W. S. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.01781 · Cited by 224 · see citing works

A new clinical trial to test high-dose vitamin C in patients with COVID-19

Carr, A. C. (2020) · Critical Care · doi:10.1186/s13054-020-02851-4 · Cited by 220 · see citing works

Molecular model of SARS coronavirus polymerase: implications for biochemical functions and drug design

Xu, X. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg916 · Cited by 218 · see citing works

SARS Vaccine Development

Jiang, S., He, Y., & Liu, S. (2005) · Emerging infectious diseases · doi:10.3201/1107.050219 · Cited by 215 · see citing works

Cytotoxic T lymphocytes are critical in the control of infectious bronchitis virus in poultry

Collisson, E. W. (2000) · Developmental & Comparative Immunology · doi:10.1016/s0145-305x(99)00072-5 · Cited by 210 · see citing works

Antibody Responses to SARS-CoV-2 in Patients of Novel Coronavirus Disease 2019Preprint

Zhao, J., Yuan, Q., Wang, H., Liu, W. Y., Liao, X., Su, Y., Wang, X., Yuan, J., Li, T., Li, J., et al. (2020) · SSRN Electronic Journal · doi:10.2139/ssrn.3546052 · Cited by 208 · see citing works

Antibody Response of Patients with Severe Acute Respiratory Syndrome (SARS) Targets the Viral Nucleocapsid

Leung, D. T. M., Tam, F. C. H., Ma, C. H., Chan, P. K. S., Cheung, J. L. K., Niu, H., Tam, J. S., & Lim, P. L. (2004) · The Journal of Infectious Diseases · doi:10.1086/422040 · Cited by 207 · see citing works

Design of a Multiepitope‐Based Peptide Vaccine against the E Protein of Human COVID‐19: An Immunoinformatics Approach

Abdelmageed, M. I., Abdelmoneim, A. H., Mustafa, M. I., Elfadol, N. M., Murshed, N. S., Shantier, S. W., & Makhawi, A. M. (2020) · BioMed Research International · doi:10.1155/2020/2683286 · Cited by 207 · see citing works

The Possible Immunological Pathways for the Variable Immunopathogenesis of COVID—19 Infections among Healthy Adults, Elderly and Children

Abdulamir, A. S., & Hafidh, R. R. (2020) · Electronic Journal of General Medicine · doi:10.29333/ejgm/7850 · Cited by 194 · see citing works

Analyzing situational awareness through public opinion to predict adoption of social distancing amid pandemic COVID‐19

Qazi, A., Qazi, J., Naseer, K., Zeeshan, M., Hardaker, G., Maitama, J. Z., & Haruna, K. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25840 · Cited by 191 · see citing works

Type I interferon susceptibility distinguishes SARS-CoV-2 from SARS-CoVPreprint

Lokugamage, K. G., Hage, A., de Vries, M., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.03.07.982264 · Cited by 189 · see citing works

Glycogen Synthase Kinase-3 Regulates the Phosphorylation of Severe Acute Respiratory Syndrome Coronavirus Nucleocapsid Protein and Viral Replication

Wu, C.-H., Yeh, S., Tsay, Y., Shieh, Y., Kao, C., Chen, Y.-S., Wang, S.-H., Kuo, T.-J., Chen, D., & Chen, P. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m805747200 · Cited by 186 · see citing works

TMPRSS2, a Serine Protease Expressed in the Prostate on the Apical Surface of Luminal Epithelial Cells and Released into Semen in Prostasomes, Is Misregulated in Prostate Cancer Cells

Chen, Y., Lee, M., Lucht, A., Chou, F., Huang, W., Havighurst, T. C., Kim, K., Wang, J.-K., Antalis, T., Johnson, M. D., et al. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.090665 · Cited by 174 · see citing works

Generation and Characterization of DNA Vaccines Targeting the Nucleocapsid Protein of Severe Acute Respiratory Syndrome Coronavirus

Kim, T. W., Lee, J. H., Hung, C., Peng, S., Roden, R. B. S., Wang, M., Viscidi, R. P., Tsai, Y.-C., He, L., Chen, P., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.9.4638-4645.2004 · Cited by 172 · see citing works

The Curious Case of the Nidovirus Exoribonuclease: Its Role in RNA Synthesis and Replication Fidelity

Ogando, N. S., Ferrón, F., Decroly, É., Canard, B., Posthuma, C. C., & Snijder, E. J. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.01813 · Cited by 155 · see citing works

Modulation of Dengue/Zika Virus Pathogenicity by Antibody-Dependent Enhancement and Strategies to Protect Against Enhancement in Zika Virus Infection

Khandia, R., Munjal, A. K., Dhama, K., Karthik, K., Tiwari, R., Malik, Y. S., Singh, R. K., & Chaicumpa, W. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00597 · Cited by 135 · see citing works

The nucleocapsid protein of SARS coronavirus has a high binding affinity to the human cellular heterogeneous nuclear ribonucleoprotein A1

Luo, H., Chen, Q., Chen, J., Chen, K., Shen, X., & Jiang, H. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.03.080 · Cited by 131 · see citing works

Therapeutic use of chloroquine and hydroxychloroquine in COVID-19 and other viral infections: A narrative review

Hashem, A. M., Alghamdi, B. S. A., Algaissi, A. A., Alshehri, F. S., Bukhari, A. I., Alfaleh, M. A., & Memish, Z. A. (2020) · Travel Medicine and Infectious Disease · doi:10.1016/j.tmaid.2020.101735 · Cited by 128 · see citing works

First respiratory transmitted food borne outbreak?

Jalava, K. (2020) · International Journal of Hygiene and Environmental Health · doi:10.1016/j.ijheh.2020.113490 · Cited by 123 · see citing works

Investigating the cases of novel coronavirus disease (COVID-19) in China using dynamic statistical techniques

Sarkodie, S. A., & Owusu, P. A. (2020) · Heliyon · doi:10.1016/j.heliyon.2020.e03747 · Cited by 123 · see citing works

Amplicon based MinION sequencing of SARS-CoV-2 and metagenomic characterisation of nasopharyngeal swabs from patients with COVID-19.

Moore, S. C., Penrice-Randal, R., Alruwaili, M., Dong, X., Pullan, S. T., Carter, D. P., Bewley, K., Zhao, Q., Sun, Y., Hartley, C., et al. (2020) · doi:10.1101/2020.03.05.20032011 · Cited by 121 · see citing works

Humoral Immune Responses in COVID-19 Patients: A Window on the State of the Art

Siracusano, G., Pastori, C., & Lopalco, L. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01049 · Cited by 110 · see citing works

Epitope-Based Vaccine Target Screening against Highly Pathogenic MERS-CoV: An In Silico Approach Applied to Emerging Infectious Diseases

Shi, J., Zhang, J., Li, S., Sun, J., Teng, Y., Wu, M., Li, J., Li, Y., Hu, N., Wang, H., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0144475 · Cited by 106 · see citing works

Tocilizumab: A Therapeutic Option for the Treatment of Cytokine Storm Syndrome in COVID-19

Saha, A., Sharma, A. R., Bhattacharya, M., Sharma, G., Lee, S., & Chakraborty, C. (2020) · Archives of Medical Research · doi:10.1016/j.arcmed.2020.05.009 · Cited by 105 · see citing works

Transmission electron microscopy imaging of SARS-CoV-2

Prasad, S., Potdar, V. A., Cherian, S., Abraham, P., & Basu, A. (2020) · The Indian Journal of Medical Research · doi:10.4103/ijmr.ijmr_577_20 · Cited by 103 · see citing works

NKG2A and COVID-19: another brick in the wall

Antonioli, L., Fornai, M., Pellegrini, C., & Blandizzi, C. (2020) · Cellular and Molecular Immunology · doi:10.1038/s41423-020-0450-7 · Cited by 97 · see citing works

Geroprotective and senoremediative strategies to reduce the comorbidity, infection rates, severity, and lethality in gerophilic and gerolavic infections

Zhavoronkov, A. A. (2020) · Aging · doi:10.18632/aging.102988 · Cited by 92 · see citing works

Efficacy of an Adjuvanted Middle East Respiratory Syndrome Coronavirus Spike Protein Vaccine in Dromedary Camels and Alpacas

Adney, D. R., Wang, L., van Doremalen, N., Shi, W., Zhang, Y., Kong, W., Miller, M. R., Bushmaker, T., Scott, D. P., de Wit, E., et al. (2019) · Viruses · doi:10.3390/v11030212 · Cited by 88 · see citing works

The Correlation between Pro- and Anti-Inflammatory Cytokines in Chronic Subdural Hematoma Patients Assessed with Factor Analysis

Pripp, A. H., & Stanišić, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090149 · Cited by 87 · see citing works

Structural Definition of a Neutralization-sensitive Epitope on the MERS-CoV S1-NTD

Wang, N., Rosen, O., Wang, L., Turner, H. L., Stevens, L. J., Corbett, K. S., Bowman, C. A., Pallesen, J., Shi, W., Zhang, Y., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.08.052 · Cited by 86 · see citing works

Adoptive Transfer of Infectious Bronchitis Virus Primed αβ T Cells Bearing CD8 Antigen Protects Chicks from Acute Infection

Seo, S. H., Pei, J., Briles, W. E., Dzielawa, J. A., & Collisson, E. W. (2000) · Virology · doi:10.1006/viro.2000.0211 · Cited by 85 · see citing works

Innate immunity in COVID-19 patients mediated by NKG2A receptors, and potential treatment using Monalizumab, Cholroquine, and antiviral agents

Yaqinuddin, A., & Kashir, J. (2020) · Medical Hypotheses · doi:10.1016/j.mehy.2020.109777 · Cited by 85 · see citing works

The recombinant N-terminal domain of spike proteins is a potential vaccine against Middle East respiratory syndrome coronavirus (MERS-CoV) infection

Jiaming, L., Yanfeng, Y., Deng, Y. L., Yawei, H., Linlin, B., Baoying, H., Jinghua, Y., Gao, G. F., Chuan, Q., & Wenjie, T. (2016) · Vaccine · doi:10.1016/j.vaccine.2016.11.064 · Cited by 84 · see citing works

2019 novel coronavirus disease (COVID-19) in Taiwan: Reports of two cases from Wuhan, China

Huang, W.-H., Teng, L.-C., Yeh, T.-K., Chen, Y.-J., Lo, W.-J., Wu, M.-J., Chin, C.-S., Tsan, Y., Lin, T., Chai, J., et al. (2020) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2020.02.009 · Cited by 84 · see citing works

A novel neutralizing monoclonal antibody targeting the N-terminal domain of the MERS-CoV spike protein

Chen, Y., Lu, S., Jia, H., Deng, Y., Zhou, J., Huang, B., Yu, Y., Lan, J., Wang, W., Lou, Y., et al. (2017) · Emerging Microbes & Infections · doi:10.1038/emi.2017.50 · Cited by 81 · see citing works

SARS-CoV-2 and SARS-CoV Spike-RBD Structure and Receptor Binding Comparison and Potential Implications on Neutralizing Antibody and Vaccine DevelopmentPreprint

Sun, C., Chen, L., Yang, J., Luo, C., Zhang, Y., Li, J., Yang, J., Zhang, J., & Xie, L. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.02.16.951723 · Cited by 77 · see citing works

DAMP-driven metabolic adaptation

Minton, K. (2019) · Nature reviews. Immunology · doi:10.1038/s41577-019-0258-9 · Cited by 76 · see citing works

Genome-Wide Screen Reveals Valosin-Containing Protein Requirement for Coronavirus Exit from Endosomes

Wong, H. H., Kumar, P., Tay, F. P., Moreau, D., Liu, D. X., & Bard, F. (2015) · Journal of Virology · doi:10.1128/jvi.01360-15 · Cited by 75 · see citing works

SARS-CoV-2 and SARS-CoV differ in their cell tropism and drug sensitivity profilesPreprint

Bojková, D., McGreig, J. E., McLaughlin, K.-M., Masterson, S. G., Widera, M., Krähling, V., Ciesek, S., Wass, M. N., Michaelis, M., & Cinatl, J. J. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.04.03.024257 · Cited by 73 · see citing works

Epitopes for a 2019-nCoV vaccine

Lucchese, G. (2020) · Cellular and Molecular Immunology · doi:10.1038/s41423-020-0377-z · Cited by 71 · see citing works

Superior immune responses induced by intranasal immunization with recombinant adenovirus-based vaccine expressing full-length Spike protein of Middle East respiratory syndrome coronavirus

Kim, M. H., Kim, H. J., & Chang, J. (2019) · PLoS ONE · doi:10.1371/journal.pone.0220196 · Cited by 63 · see citing works

Interferon gamma-induced protein 10 is associated with insulin resistance and incident diabetes in patients with nonalcoholic fatty liver disease

Chang, C.-C., Wu, C.-L., Su, W.-W., Shih, K., Tarng, D., Chou, C.-T., Chen, T.-Y., Kor, C., & Wu, H.-M. (2015) · Scientific Reports · doi:10.1038/srep10096 · Cited by 55 · see citing works

New coronavirus threat galvanizes scientists

Cohen, J. D. (2020) · Science · doi:10.1126/science.367.6477.492 · Cited by 55 · see citing works

Identification of the immunodominant neutralizing regions in the spike glycoprotein of porcine deltacoronavirus

Chen, R., Fu, J., Hu, J., Li, C., Zhao, Y., Qu, H., Wen, X., Cao, S., Wen, Y., Wu, R. J., et al. (2019) · Virus Research · doi:10.1016/j.virusres.2019.197834 · Cited by 52 · see citing works

Convalescent serum lines up as first-choice treatment for coronavirus

Sheridan, C. (2020) · Nature Biotechnology · doi:10.1038/d41587-020-00011-1 · Cited by 49 · see citing works

Characterization of novel monoclonal antibodies against MERS-coronavirus spike protein

Goo, J., Jeong, Y., Park, Y.-S., Yang, E., Jung, D., Rho, S., Park, U., Sung, H., Park, P., Choi, J., et al. (2020) · Virus Research · doi:10.1016/j.virusres.2020.197863 · Cited by 47 · see citing works

Coronavirus disease 2019 (COVID-19): We don’t leave women alone.

Mantovani, A., Dalbeni, A., & Beatrice, G. (2020) · International Journal of Public Health · doi:10.1007/s00038-020-01369-4 · Cited by 42 · see citing works

Cross-neutralization of SARS coronavirus-specific antibodies against bat SARS-like coronaviruses

Zeng, L., Ge, X., Peng, C., Tai, W., Jiang, S., Du, L., & Shi, Z. (2017) · Science China Life Sciences · doi:10.1007/s11427-017-9189-3 · Cited by 39 · see citing works

A Fusion Peptide in the Spike Protein of MERS Coronavirus

Alsaadi, E. A. J., Neuman, B. W., & Jones, I. M. (2019) · Viruses · doi:10.3390/v11090825 · Cited by 39 · see citing works

Human transbodies that interfere with the functions of Ebola virus VP35 protein in genome replication and transcription and innate immune antagonism

Seesuay, W., Jittavisutthikul, S., Saelim, N., Sookrung, N., Sakolvaree, Y., & Chaicumpa, W. (2018) · Emerging Microbes & Infections · doi:10.1038/s41426-018-0031-3 · Cited by 37 · see citing works

Author Correction: COVID-19: the vasculature unleashed

Teuwen, L.-A. M. N., Geldhof, V., Pasut, A., & Carmeliet, P. (2020) · Nature reviews. Immunology · doi:10.1038/s41577-020-0356-8 · Cited by 35 · see citing works

Characterization of the Immune Response of MERS-CoV Vaccine Candidates Derived from Two Different Vectors in Mice

Li, E., Yan, F., Huang, P., Chi, H., Xu, S., Li, G., Liu, C., Feng, N., Wang, H., Zhao, Y., et al. (2020) · Viruses · doi:10.3390/v12010125 · Cited by 30 · see citing works

Evidence of the Recombinant Origin and Ongoing Mutations in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)Preprint

Huang, J.-M., Jan, S. S., Wei, X., Wan, Y., & Ouyang, S. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.03.16.993816 · Cited by 22 · see citing works

[Progress and challenge of vaccine development against 2019-novel coronavirus (2019-nCoV)].

Shi, Y., Wang, N., & Zou, Q. (2020) · PubMed · doi:10.3760/cma.j.cn112150-20200317-00366 · Cited by 21 · see citing works

Are We Ready for Coronavirus Disease 2019 Arriving at Schools?

Choe, Y. J., & Choi, E. H. (2020) · Journal of Korean Medical Science · doi:10.3346/jkms.2020.35.e127 · Cited by 20 · see citing works

Possible method for the production of a Covid‐19 vaccine

Myint, A., & Jones, T. O. (2020) · Veterinary Record · doi:10.1136/vr.m1193 · Cited by 6 · see citing works

Advances in COVID-19 mRNA vaccine development

Fang, E., Liu, X., Li, M., Zhang, Z., Song, L., Zhu, B., Wu, X., Liu, J., Zhao, D., & Li, Y. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00950-y · Cited by 601 · see citing works

Potential Clinical Benefits of Quercetin in the Early Stage of COVID-19: Results of a Second, Pilot, Randomized, Controlled and Open-Label Clinical Trial

Di Pierro, F., Iqtadar, S., Khan, A., Ullah Mumtaz, S., Masud Chaudhry, M., Bertuccioli, A., Derosa, G., Maffioli, P., Togni, S., Riva, A., et al. (2021) · International Journal of General Medicine · doi:10.2147/ijgm.s318949 · Cited by 180 · see citing works

A global picture: therapeutic perspectives for COVID-19

Chavda, V., Kapadia, C., Soni, S., Prajapati, R., Chauhan, S., Yallapu, M., & Apostolopoulos, V. (2022) · Immunotherapy · doi:10.2217/imt-2021-0168 · Cited by 66 · see citing works

Pathophysiology and clinical management of coronavirus disease (COVID-19): a mini-review

Zhu, Y., Sharma, L., & Chang, D. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1116131 · Cited by 48 · see citing works

Intelligent algorithms and complex system for a smart parking for vaccine delivery center of COVID-19

Jemmali, M., & Fayez, F. A. (2021) · Complex & Intelligent Systems · doi:10.1007/s40747-021-00524-5 · Cited by 41 · see citing works

Pathological Findings in COVID-19 as a Tool to Define SARS-CoV-2 Pathogenesis. A Systematic Review

Mondello, C., Roccuzzo, S., Malfa, O., Sapienza, D., Gualniera, P., Spagnolo, E. V., Nunno, N. R. D., Salerno, M., Pomara, C., & Asmundo, A. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.614586 · Cited by 33 · see citing works

Neurologic manifestations in children with COVID-19 from a tertiary center in Turkey and literature review

Gürlevik, S. L., Günbey, C., Özsürekçi, Y., Oygar, P. D., Kesici, S., Göçmen, R., Aydın, O., Temuçin, Ç. M., Tufan, E., Terzi, K., et al. (2022) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2022.02.003 · Cited by 31 · see citing works

A randomized, placebo-controlled, double-blinded pilot study of angiotensin 1–7 (TXA-127) for the treatment of severe COVID-19

Wagener, G., Goldklang, M. P., Gerber, A. M., Elisman, K., Eiseman, K. A., Fonseca, L. D., & D'Armiento, J. M. (2022) · Critical Care · doi:10.1186/s13054-022-04096-9 · Cited by 29 · see citing works

Macular vessel density reduction in patients recovered from COVID-19: a longitudinal optical coherence tomography angiography study

Abrishami, M., Hassanpour, K., Hosseini, S. M., Emamverdian, Z., Astaneh, M. R. A., Zamani, G., Gharib, B., & Abrishami, M. (2021) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-021-05429-0 · Cited by 28 · see citing works

LC-MS/MS: A sensitive and selective analytical technique to detect COVID-19 protein biomarkers in the early disease stage

Gajula, S. N. R., Khairnar, A. S., Jock, P., Kumari, N., Pratima, K., Munjal, V., Kalan, P., & Sonti, R. (2023) · Expert Review of Proteomics · doi:10.1080/14789450.2023.2191845 · Cited by 23 · see citing works

Drug repositioning in the COVID-19 pandemic: fundamentals, synthetic routes, and overview of clinical studies

Vaz, E. S., Vassiliades, S. V., Giarolla, J., Polli, M. C., & Parise‐Filho, R. (2023) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-023-03486-4 · Cited by 24 · see citing works

The importance of genomic analysis in cracking the coronavirus pandemic

Zella, D., Giovanetti, M., Cella, E., Borsetti, A., Ciotti, M., Ceccarelli, G., d’Ettorre, G., Pezzuto, A., Tambone, V., Campanozzi, L. L., et al. (2021) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2021.1917998 · Cited by 22 · see citing works

COVID-19 and solid organ transplantation: Finding the right balance

Opsomer, R., & Kuypers, D. R. J. (2022) · Transplantation Reviews · doi:10.1016/j.trre.2022.100710 · Cited by 20 · see citing works

After the Hurricane: Anti-COVID-19 Drugs Development, Molecular Mechanisms of Action and Future Perspectives

Khalifa, H. O., & Ramahi, Y. A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25020739 · Cited by 20 · see citing works

Temporal Changes in the Oxyhemoglobin Dissociation Curve of Critically Ill COVID-19 Patients

Ceruti, S., Minotti, B., Glotta, A., Biggiogero, M., Bona, G., Marzano, M., Greco, P., Spagnoletti, M., Garzoni, C., & Bendjelid, K. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11030788 · Cited by 19 · see citing works

The utility of SARS‐CoV‐2 nucleocapsid protein in laboratory diagnosis

Li, X., Xiong, M., Deng, Q., Guo, X., & Li, Y. (2022) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.24534 · Cited by 19 · see citing works

Lessons from SARS-CoV, MERS-CoV, and SARS-CoV-2 Infections: What We Know So Far

Alsafi, R. (2022) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2022/1156273 · Cited by 20 · see citing works

Molecular Docking Simulation Studies, Toxicity Study, Bioactivity Prediction, and Structure-Activity Relationship Reveals Rutin as a Potential Inhibitor of SARS-CoV-2 3CL pro

Zothantluanga, J. H. (2021) · Journal of scientific research · doi:10.37398/jsr.2021.650511 · Cited by 16 · see citing works

Corilagin and 1,3,6-Tri- O -galloy-β- d -glucose: potential inhibitors of SARS-CoV-2 variants

Binette, V., Côté, S., Haddad, M., Nguyen, P. T., Bélanger, S., Bourgault, S., Ramassamy, C., Gaudreault, R., & Mousseau, N. (2021) · Physical Chemistry Chemical Physics · doi:10.1039/d1cp01790j · Cited by 16 · see citing works

Establishment of a pseudovirus neutralization assay based on SARS-CoV-2 S protein incorporated into lentiviral particles

Wang, S., Liu, L., Wang, C., Wang, Z., Duan, X., Chen, G., Zhou, H., & Shao, H. (2022) · Biosafety and Health · doi:10.1016/j.bsheal.2021.12.006 · Cited by 16 · see citing works

Relevance of BET Family Proteins in SARS-CoV-2 Infection

Lara-Ureña, N., & García‐Domínguez, M. (2021) · Biomolecules · doi:10.3390/biom11081126 · Cited by 15 · see citing works

Characterization of Clinical Features of Hospitalized Patients Due to the SARS-CoV-2 Infection in the Absence of Comorbidities Regarding the Sex: An Epidemiological Study of the First Year of the Pandemic in Brazil

Sansone, N. M. S., Pereira, L. R., Boschiero, M. N., Valencise, F. E., Fraga, A. D. M. A., & Marson, F. A. L. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19158895 · Cited by 16 · see citing works

Biomarkers Predict In-Hospital Major Adverse Cardiac Events in COVID-19 Patients: A Multicenter International Study

Henein, M. Y., Mandoli, G. E., Pastore, M. C., Ghionzoli, N., Hasson, F., Nisar, M. K., Islam, M. M., Bandera, F., Marrocco-Trischitta, M. M., Baroni, I., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10245863 · Cited by 14 · see citing works

Malaria Epidemiology and COVID-19 Pandemic: Are They Interrelated?

Prabhu, S. R., Ware, A. P., Saadi, A. V., Brand, A. M., Ghosh, S. K., Kamath, A., & Satyamoorthy, K. (2022) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2021.0227 · Cited by 14 · see citing works

Micronutrient perspective on COVID-19: Umbrella review and reanalysis of meta-analyses

Xie, Y., Xu, J., Zhou, D., Guo, M., Zhang, M., Gao, Y., Liu, M., Shi, J., Yang, K., Zheng, Q., et al. (2023) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2023.2174948 · Cited by 13 · see citing works

COVID-19 in the perioperative setting: A review of the literature and the clinical landscape

O’Glasser, A. Y., & Schenning, K. J. (2022) · Perioperative Care and Operating Room Management · doi:10.1016/j.pcorm.2022.100272 · Cited by 12 · see citing works

Meta-analysis of the systemic immune-inflammatory index and in-hospital mortality of COVID-19 patients

Hao, Y. T., Tian, J., & Wen, L. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e23441 · Cited by 12 · see citing works

Computational analysis of spike protein of SARS-CoV-2 (Omicron variant) for development of peptide-based therapeutics and diagnostics

Pritam, M., Dutta, S., Medicherla, K. M., Kumar, R., & Singh, S. P. (2023) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2023.2239932 · Cited by 11 · see citing works

The Impact of Coronavirus Disease 2019 on Pediatric Asthma in the United States

Navalpakam, A., Secord, E. A., & Pansare, M. V. (2021) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2021.05.012 · Cited by 11 · see citing works

Outcomes of COVID-19 in Inflammatory Rheumatic Diseases: A Retrospective Cohort Study

Alhowaish, T. S., Alhamadh, M. S., Alhabeeb, A. Y., Aldosari, S. F., Masuadi, E., & Alrashid, A. (2022) · Cureus · doi:10.7759/cureus.26343 · Cited by 11 · see citing works

Nitric Oxide and its Derivatives Containing Nasal Spray and Inhalation Therapy for the Treatment of COVID-19

Chavda, V. P., Vora, L. K., Singla, R. K., Patel, A., Shah, P., Uversky, V. N., & Apostolopoulos, V. (2022) · Current Pharmaceutical Design · doi:10.2174/1381612829666221024124848 · Cited by 11 · see citing works

Synthesis of Structural ADP-Ribose Analogues as Inhibitors for SARS-CoV-2 Macrodomain 1

Rijpkema, K. J., Schuller, M., van der Veer, M. S., Rieken, S., Chang, D. L. R., Balić, P., Todorov, A. G., Minnee, H., Wijngaarden, S., Matos, I. D. A., et al. (2024) · Organic Letters · doi:10.1021/acs.orglett.4c01792 · Cited by 10 · see citing works

Comparative efficacy and safety of pharmacological interventions for severe COVID-19 patients: An updated network meta-analysis of 48 randomized controlled trials

Cheng, Q., Zhao, G., Chen, J., Jia, Q., & Fang, Z. (2022) · Medicine · doi:10.1097/md.0000000000030998 · Cited by 10 · see citing works

Recent Advancements on COVID-19: A Comprehensive Review

Rahman, H. S., Abdulateef, D. S., Hussen, N. H., Salih, A. F., Othman, H. H., Abdulla, T. M., Omer, S. H. S., Mohammed, T. H., Mohammed, M. O., Aziz, M. S., et al. (2021) · International Journal of General Medicine · doi:10.2147/ijgm.s339475 · Cited by 10 · see citing works

The RAAS Axis and SARS-CoV-2: From Oral to Systemic Manifestations

Maranducă, M. A., Vamesu, C. G., Tănase, D. M., Clim, A., Drochioi, I. C., Pînzariu, A. C., Filip, N., Dima, N., Tudorancea, I., Șerban, D. N., et al. (2022) · Medicina · doi:10.3390/medicina58121717 · Cited by 10 · see citing works

Comparative cohort analysis of pressure ulcer/injury in intensive care unit patients before and during the COVID-19 pandemic

Oliveira, F. V., Coltro, P. S., Nunes, A. A., Biaziolo, C. F. B., Ferreira, M. C., & Farina, J. A. (2023) · Journal of Plastic Reconstructive & Aesthetic Surgery · doi:10.1016/j.bjps.2023.06.072 · Cited by 9 · see citing works

SARS-COV-2 protein NSP9 promotes cytokine production by targeting TBK1

Zhang, Y., Xin, B., Liu, Y., Jiang, W., Han, W., Deng, J., Wang, P., Hong, X., & Yan, D. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1211816 · Cited by 9 · see citing works

Revisiting the dimensions of universal vaccine with special focus on COVID-19: Efficacy versus methods of designing

Jaishwal, P., Jha, K., & Singh, S. P. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.134012 · Cited by 10 · see citing works

Ischemic stroke leading to bilateral vision loss in COVID‐19 patient—A rare case report

Khan, A. W., Ullah, I., & Khan, K. S. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26484 · Cited by 9 · see citing works

Anticoagulation treatment for patients with coronavirus disease 2019 (COVID-19) and its clinical effectiveness in 2020

Ge, J., Ma, Y., Wu, Z., Jin, J., & Sun, X. (2021) · Medicine · doi:10.1097/md.0000000000027861 · Cited by 8 · see citing works

Predicting 30 – Day outcomes in emergency department patients discharged with COVID-19

McKay, B., Meyers, M., Rivard, L., Stoltzfus, J. C., Rammohan, G., & Stankewicz, H. (2021) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2021.08.077 · Cited by 8 · see citing works

In silico Study of Potential anti-SARS Cell Entry Phytoligands From Phlomis aurea : A Promising Avenue for Prophylaxis

Khattab, A. R., Teleb, M., & Kamel, M. S. (2021) · Future Virology · doi:10.2217/fvl-2021-0031 · Cited by 8 · see citing works

Dynamic of Serum TWEAK Levels in Critically Ill COVID-19 Male Patients

Mikačić, M., Kumrić, M., Baricevic, M., Tokić, D., Stipić, S. S., Cvitković, I., Šupe‐Domić, D., Kurir, T. T., & Božić, J. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11133699 · Cited by 8 · see citing works

Performance of oxygenation indices and risk scores to predict invasive mechanical ventilation and mortality in COVID-19

Bastidas, A., Tuta-Quintero, E., Aguilar, M. F. D., Mora, A., Murcia, C. A., Villamizar, J. M., Galeano, S., Mejía, P., Muñoz, M., Paredes, S., et al. (2024) · BMC Pulmonary Medicine · doi:10.1186/s12890-023-02807-8 · Cited by 8 · see citing works

COVID‐19 susceptibility in endometriosis patients: A case control study

Barretta, M., Savasta, F., Pietropaolo, G., di Prun, A. B., Barbera, V., & Vignali, M. (2022) · American Journal of Reproductive Immunology · doi:10.1111/aji.13602 · Cited by 7 · see citing works

SARS-CoV-2 Infection to Premature Neuronal Aging and Neurodegenerative Diseases: Is there any Connection with Hypoxia?

Sivagurunathan, N., & Latchoumycandane, C. (2023) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527322666230418114446 · Cited by 7 · see citing works

Investigating the shared genetic architecture between COVID-19 and obesity: a large-scale genome wide cross-trait analysis

Chen, Y., Fan, C., & Liu, J. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1325939 · Cited by 7 · see citing works

Iterative In Silico Screening for Optimizing Stable Conformation of Anti-SARS-CoV-2 Nanobodies

Shang, W., Hu, X., Lin, X., Li, S., Xiong, S., Huang, B., & Wang, X. (2024) · Pharmaceuticals · doi:10.3390/ph17040424 · Cited by 7 · see citing works

Bacterial infections in COVID-19 patients: a review

Grinbaum, R. S., & Kiffer, C. R. V. (2021) · Revista da Associação Médica Brasileira · doi:10.1590/1806-9282.20210812 · Cited by 9 · see citing works

The role of HLA genotypes in understanding the pathogenesis of severe COVID-19

Arab, F., Mollazadeh, S., Ghayourbabaei, F., Moghbeli, M., & Saburi, E. (2023) · Egyptian Journal of Medical Human Genetics · doi:10.1186/s43042-023-00392-3 · Cited by 7 · see citing works

Retroperitoneal and abdominal bleeding in anticoagulated COVID-19 hospitalized patients: Case series and brief literature review

Evrev, D., Sekulovski, M., Gulinac, M., Dobrev, H. P., Velikova, T. V., & Hadjidekov, G. (2023) · World Journal of Clinical Cases · doi:10.12998/wjcc.v11.i7.1528 · Cited by 7 · see citing works

When Frequent (Pandemic) Occurs in a Non-Frequent Disease: COVID-19 and Fabry Disease: Report of Two Cases

Gómez-Luján, M., Cruzalegui, C., Aguilar, C., Álvarez-Vargas, M. L., & Segura-Saldaña, P. (2020) · Japanese Journal of Infectious Diseases · doi:10.7883/yoken.jjid.2020.729 · Cited by 7 · see citing works

Coinfection with severe acute respiratory syndrome coronavirus‐2 and other respiratory viruses at a tertiary hospital in Korea

Kim, Z., & Lee, J. H. (2021) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.23868 · Cited by 6 · see citing works

Analysis of Optical Coherence Tomography (OCT) and Optical Coherence Tomography Angiography (OCTA) Parameters in Young Adults after SARS-CoV-2 Infection (COVID-19) Compared with Healthy Young Controls

Bajka, A., Muth, D. R., Wiest, M. R. J., Said, S., Rejdak, M. B., Sidhu, S., Foa, N., Blaser, F., Barthelmes, D., Toro, M. D., et al. (2023) · Diagnostics · doi:10.3390/diagnostics13071283 · Cited by 6 · see citing works

Síndrome de burnout: Una realidad percibida por los docentes universitarios en el trabajo virtual en tiempos de covid-19

Rivera, L. D. J. I., Pacheco, J. M. A., Crispín, F. V. S., & Espinoza, J. O. (2021) · Boletín de Malariología y Salud Ambiental · doi:10.52808/bmsa.7e5.612.025 · Cited by 6 · see citing works

Effect of lactoferrin treatment on symptoms and physical performance in long COVID patients: a randomised, double-blind, placebo-controlled trial

Redel, A.-L., Miry, F., Hellemons, M. E., Oswald, L., & Braunstahl, G. (2024) · ERJ Open Research · doi:10.1183/23120541.00031-2024 · Cited by 6 · see citing works

The COVID-19 Patient in the Surgical Intensive Care Unit

Monroe, I., Dale, M. A., Schwabe, M. J., Schenkel, R., & Schenarts, P. J. (2021) · Surgical Clinics of North America · doi:10.1016/j.suc.2021.09.015 · Cited by 6 · see citing works

The renin-angiotensin system and specifically angiotensin-converting enzyme 2 as a potential therapeutic target in SARS-CoV-2 infections

Ferrara, F., & Vitiello, A. (2021) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-021-02108-z · Cited by 6 · see citing works

Correction to: The renin‑angiotensin system and specifically angiotensin‑converting enzyme 2 as a potential therapeutic target in SARS‑CoV‑2 infections

Ferrara, F., & Vitiello, A. (2021) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-021-02165-4 · Cited by 6 · see citing works

Severe Acute Respiratory Syndrome Associated Infections

Luu, B., Hass, V. M., Kadiu, T., Ngo, V., Kadiu, S., & Lien, J. (2023) · Physician Assistant Clinics · doi:10.1016/j.cpha.2023.03.002 · Cited by 5 · see citing works

Exploring the Impact of Herbal Therapies on COVID-19 and Influenza: Investigating Novel Delivery Mechanisms for Emerging Interventions

Laurindo, L. F., Marton, L. T., Minniti, G., Rodrigues, V. D., Suzuki, R. B., Catharin, V. M. C. S., Joshi, R. K., & Barbalho, S. M. (2023) · Biologics · doi:10.3390/biologics3030009 · Cited by 4 · see citing works

COVID-19 Related Retinal Vascular Occlusion: A Systematic Review

Tzamalis, A. K., Foti, M., Georgiadou, M., Tsaftaridis, N., & Ziakas, N. G. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14041183 · Cited by 4 · see citing works

Awareness of Forensic Odontology among Dentists in Pakistan and its Impact on Dental Record Keeping

Tahir, F., Raja, H. Z., Saleem, M. N., Iqbal, A., Ullah, M. S., & Yasser, F. (2022) · Pakistan Journal of Medical and Health Sciences · doi:10.53350/pjmhs2216892 · Cited by 4 · see citing works

Post-COVID-19 Syndrome: Audiometric Findings in Patients with Audiological Symptoms

Coronado, O. O. R., Félix, C. A. I., Flores, G. P., Márquez, M. E. D. A., Contreras, C. R. C., González-Díaz, E., Paz, A. I. S., & Lucano, L. R. G. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20176697 · Cited by 4 · see citing works

Incidence, clinical characteristics and outcome of barotrauma in critically ill patients with COVID-19: a systematic review and meta-analysis

Umbrello, M., Venco, R., Antonucci, E., Cereghini, S., Filardo, C., Guglielmetti, L., MONTANARI, G., & Muttini, S. (2022) · Minerva Anestesiologica · doi:10.23736/s0375-9393.22.16258-9 · Cited by 4 · see citing works

Contrast‑induced acute kidney injury in COVID-19 patients

Gücün, M., & Isik, M. E. (2021) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.4149/bll_2021_103 · Cited by 3 · see citing works

Case report of actinomycotic liver abscess following COVID-19 infection

Lévay, K., Daradics, N., Horváth, T., Kovács, T., Fulop, A. K., Oláh, A., & Szíjártó, A. (2022) · Annals of Medicine and Surgery · doi:10.1016/j.amsu.2022.104525 · Cited by 3 · see citing works

Profissionais da saúde e as repercussões associadas a saúde mental, no período pandêmico

Vilela, R. E. R. V., Santo, F. S., da Silva, T. A., Vasque, W. G., & Marinho, C. A. F. (2022) · Revista Omnia Saúde · doi:10.29327/4185543 · Cited by 3 · see citing works

Pneumonia-associated microbial species and stabilized chlorine dioxide–containing oral care products

Ayoub, H. M., Sharma, C., & Gregory, R. L. (2023) · JADA Foundational Science · doi:10.1016/j.jfscie.2023.100028 · Cited by 3 · see citing works

Healing through herbs: everaging herbal remedies against COVID-19

Beladiya, U., Chaliha, J., Mevada, V. A., Gandhi, H. R., & Patel, R. K. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15383-9.00015-9 · Cited by 3 · see citing works

Derivation and external validation of predictive models for invasive mechanical ventilation in intensive care unit patients with COVID-19

Maia, G., Martins, C. M., Marques, V., Christovam, S., Prado, I., Moraes, B., Rezoagli, E., Foti, G., Zambelli, V., Cereda, M. F., et al. (2024) · Annals of Intensive Care · doi:10.1186/s13613-024-01357-4 · Cited by 3 · see citing works

Shared genetic architecture between COVID-19 and irritable bowel syndrome: a large-scale genome-wide cross-trait analysis

Liu, X., Li, D., Gao, W., Liu, H., Chen, P., Zhao, Y., Zhao, W., & Dong, G. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1442693 · Cited by 3 · see citing works

Chest CT Findings and SARS-CoV-2 Infection in Trauma Patients—Is There a Prediction towards Higher Complication Rates?

Scheurer, F. A., Halvachizadeh, S., Berk, T., Pape, H., & Pfeifer, R. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11216401 · Cited by 3 · see citing works

SARS-CoV-2 Spike Protein Interaction Space

Lungu, C. N., & Putz, M. V. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512058 · Cited by 2 · see citing works

JN.1: The new COVID-19 variant of concern?

Dhar, R., Aidasani, H., Sahoo, O. S., Kumar, A., & Karmakar, S. (2024) · Asian Journal of Medical Sciences · doi:10.3126/ajms.v15i2.61144 · Cited by 2 · see citing works

Prognostic significance of the chemerin level in coronavirus disease 2019 patients

Gökdemir, G. Ş., Gökdemir, M. T., Araç, S., & Yokuş, B. (2024) · Medicine · doi:10.1097/md.0000000000037743 · Cited by 2 · see citing works

Lessons from COVID‐19: Aspects of prevention, therapeutics, and diagnostics against SARS‐CoV‐2 with special focus on JN.1 and XBB sublineages

Jaishwal, P., Gyaneshwari, U., Jha, K., Pandey, B., Yadav, T. P., & Singh, S. P. (2024) · MedComm – Future Medicine · doi:10.1002/mef2.90 · Cited by 2 · see citing works

Optic nerve head alterations after COVID-19: an optical coherence tomography angiography-based longitudinal study

Abrishami, M., Hassanpour, K., Bayat, K., Hosseini, S. M., Amini, N., Abrishami, M., Ensan, P. S., & Heidarzadeh, H. R. (2024) · Journal of International Medical Research · doi:10.1177/03000605241263236 · Cited by 2 · see citing works

Myocarditis as a serious complication of COVID-19

Flato, U. A. P., Biteli, P., Reina, D. O. B. R., Reina, F. T. R., Araújo, A. C., de Souza, G. A., Campanari, G. S. D. S., Matias, J. N., Lima, V. M., Zutin, T. L. M., et al. (2021) · International Journal of Advanced Engineering Research and Science · doi:10.22161/ijaers.83.3 · Cited by 2 · see citing works

Coagulopatias associadas à infecção por COVID-19: uma revisão de literatura

da Silva, A. R. F., de Oliveira, B. R., Bastos, B. S., Fraga, D. D. R., Souto, K. D. O. L., Nunes, M. E. F., Souza, P. C., Miaki, R. O., de Castro, Y. F. R., & Lopes, B. A. (2021) · Revista Eletrônica Acervo Saúde · doi:10.25248/reas.e8589.2021 · Cited by 2 · see citing works

Efecto a largo plazo de la infección por SARS-CoV-2: Síndrome neurológico post-Covid-19

Caballero-Alvarado, J., Camacho-Vargas, E., & Rojas-Sánchez, P. (2021) · Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo · doi:10.35434/rcmhnaaa.2021.143.1284 · Cited by 2 · see citing works

Aspectos fisiopatológicos envolvidos na sintomatologia da COVID-19 e suas consequências: uma revisão bibliográfica de literatura

de Sales, P. H., Hery, S. K., & Besson, J. C. F. (2022) · Research Society and Development · doi:10.33448/rsd-v11i13.35441 · Cited by 2 · see citing works

Relación clínica entre la artritis reactiva y la infección por SARS-CoV-2: una revisión exploratoria

Tuta-Quintero, E., Santacruz, J. C., Camacho, J., Olivella, J., Collazos, E., Gómez, J. C., Ochoa, D. A., Salazar-Villa, J., Rodríguez, J. E., Pérez, D. F., et al. (2023) · Revista Colombiana de Reumatología · doi:10.1016/j.rcreu.2023.04.001 · Cited by 2 · see citing works

Imunopatologia induzida por COVID-19: avaliação da resposta imune inata e adaptativa

Bonjorno, L. P., Lopes, M. I. F., Louzada‐Júnior, P., & de Oliveira, R. D. R. (2020) · Revista Paulista de Reumatologia · doi:10.46833/reumatologiasp.2020.19.3.6-11 · Cited by 2 · see citing works

THE LEGAL ACT ON COUNTERFEITING THE COVID-19 VACCINE IN INDONESIAN HEALTH LAW

Lasmadi, S. (2021) · International Journal of Law Reconstruction · doi:10.26532/ijlr.v5i2.17545 · Cited by 2 · see citing works

Biomimetic lung-targeted nanomedicine: From chemical biology to respiratory disease therapy

Wu, S.-H., Lu, B., Chen, H., Yang, Y., Zhang, J., Guo, T., Liu, H., Han, J., Fan, X., & Li, H. (2026) · Journal of Controlled Release · doi:10.1016/j.jconrel.2026.115264 · Cited by 1 · see citing works

Substance Use Disorder and COVID-19; Forensic Medicine and Pharmacology Perspectives: A Concise Narrative Review

Ali, A. S., Zughaibi, T. A., & Shaker, A. A. (2021) · Arab Journal of Forensic Sciences and Forensic Medicine · doi:10.26735/jabo2616 · Cited by 1 · see citing works

Probable treatment options for Covid-19: A brief review

Kulkarni, P. D., Nair, S. M., Kadam, S. C., Jankar, Y. A., Derashri, A., Badadhe, S. G., & Ghante, M. R. (2022) · IP International Journal of Comprehensive and Advanced Pharmacology · doi:10.18231/j.ijcaap.2022.004 · Cited by 1 · see citing works

Proposing a Multisystem Swallowing Framework: A Network Medicine Approach in the Era of COVID-19

Letawsky, V. H., Schreiber, A.-M., Dawson, C., Fullerton, G., Jones, R. C., Newton, K., Oveisi, N., Tejpar, T., & Skoretz, S. A. (2022) · Perspectives of the ASHA Special Interest Groups · doi:10.1044/2022_persp-21-00298 · Cited by 1 · see citing works

Molnupiravir - the First Oral Antiviral for COVID-19: A Literature Review

Afni, N., & Suharjono, S. (2022) · Pharmacon Jurnal Farmasi Indonesia · doi:10.23917/pharmacon.v19i1.17330 · Cited by 1 · see citing works

INTERAÇÃO DO INFLAMASSOMA COM AS DOENÇAS RESPIRATÓRIAS

Teixeira, L. M., Barros, I. S., de Sicco, G. S., Mendes, B. V. D. A., Pinatti, M. S., Tefé‐Silva, C., & Zoccal, K. F. (2023) · RECIMA21 - Revista Científica Multidisciplinar · doi:10.47820/recima21.v4i1.2632 · Cited by 1 · see citing works

COVID-19 and Hearing: Pure Tone, Speech, and High-Frequency Audiometry

Gökay, N. Y., CESUR, G., & Karamert, R. (2024) · Journal of the American Academy of Audiology · doi:10.1055/s-0044-1790278 · Cited by 1 · see citing works

Melatonin’s Impact on Cytokine Storm and Modulation of Purinergic Receptors for COVID-19 Prognosis: A Mental Health Perspective

Bertollo, A. G., Dalazen, J. B., Cassol, J. V., Hellmann, M. B., Mota, T. L., Ignácio, Z. M., & Bagatini, M. D. (2024) · Journal of Molecular Neuroscience · doi:10.1007/s12031-024-02292-6 · Cited by 1 · see citing works

Testes sorológicos no diagnóstico da Covid-19

de Assis, L. C., Souza, T. I. M. E., Aninger, G. T., & Moura, A. S. (2021) · Conexão Ciência (Online) · doi:10.24862/cco.v15i4.1312 · Cited by 1 · see citing works

Association of Chest X- ray findings with SARS-CoV-2 severity

Sidhwani, S. K., Raza, S. A., Zaina, F., Abbas, A. H., Shaikh, O. A., & Manan, S. (2022) · Pakistan Journal of Medical and Health Sciences · doi:10.53350/pjmhs2216888 · Cited by 1 · see citing works

Protocolo de reabilitação da síndrome pós-COVID-19 na atenção primária

Batista, A. R., Mendes, D. D. S., de Lima, F. A., da Silva, G. G., Marcate, T. B., & Faganello, F. R. (2022) · Research Society and Development · doi:10.33448/rsd-v11i13.35400 · Cited by 1 · see citing works

Unpacking COVID-19 Systems Biology in Lung and Whole Blood with Transcriptomics and miRNA Regulators

Anatolou, D., Dovrolis, N., Ragia, G., Kolios, G. C., & Manolopoulos, V. G. (2022) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2022.0104 · Cited by 1 · see citing works

COVID-19

(2020) · Revista Paulista de Reumatologia · doi:10.46833/reumatologiasp.2020.19.3 · Cited by 1 · see citing works

Biomarcadores y mortalidad por SARS-CoV-2 en pacientes del servicio de urgencias respiratorias

Sánchez-Sánchez, P. I., Jarquín, P. S., Vázquez, M. D. L. L. L., la Peña, E. C.-D., & Cuatepotzo-Xochihua, D. (2021) · Revista de Educaci�n e Investigaci�n en Emergencias · doi:10.24875/reie.21000022

Diabetes mellitus y COVID-19: ¿Un ciclo vicioso?

Flores-Díaz, A., & Hinojosa-Pérez, B. (2021) · REMUS - Revista Estudiantil de Medicina de la Universidad de Sonora · doi:10.59420/remus.6.2021.6

COVID Diagnostics: From Molecules to Omics

Chikomba, C. E., Dlamini, S., George, J. A., & Pillay, T. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-28012-2_7 · Cited by 1 · see citing works

Recent developments and opportunities in fighting COVID-19

Rao, V., & Bhattamisra, S. K. (2020) · Coronaviruses · doi:10.2174/2666796701999201204120422 · Cited by 3 · see citing works

A review on clinical, pathological characteristics and drug designing for COVID-19

Ashraf, M. U., Sharif, S., Ahmad, M. U., Zahid, M. N., & Mukhtar, H. (2021) · Arab Journal of Basic and Applied Sciences · doi:10.1080/25765299.2020.1836812 · Cited by 2 · see citing works

Human genetic basis of coronavirus disease 2019

Deng, H., Yan, X., & Yuan, L.-M. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00736-8 · Cited by 35 · see citing works

Genetic and structure of novel coronavirus COVID-19 and molecular mechanisms in the pathogenicity of coronaviruses

Yousefi, B., & Eslami, M. (2021) · Reviews in Medical Microbiology · doi:10.1097/mrm.0000000000000265 · Cited by 8 · see citing works